Supporting small domestic trials cost effectively

Simplify™ deployed for 70% less than fully customised IRT platform

For years, a major, multi-national pharmaceutical company has relied on a highly customised IRT platform to manage the majority of its large, global studies. Almac’s full-featured IXRS®3, as customised for the company, is replete with a vast number of enhancements and data integration capabilities. Yet, the system, no matter how advantageous in most circumstances, was going to be excessive for the needs of a program of domestic trials in Japan. Could Almac offer its long-standing partner a solution scaled to fit the trials’ budget and less complex protocols?

Download the case study now.